Seeking Alpha

Boston Scientific (BSX +0.2%) gets an upgrade to Overweight on valuation at Barclays today,...

Boston Scientific (BSX +0.2%) gets an upgrade to Overweight on valuation at Barclays today, citing cost cutting efforts, improvement in its CRM and DES businesses and a healthy pipeline. The firm also ups its price target to $7 from $6.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)